Brand-Name vs Compounded GLP-1: A 2026 Decision Framework Patients in 2026 have three realistic supply paths: insurance-covered brand-name (Wegovy, Zepbound, Ozempic, Mounjaro), cash-pay brand-name via manufacturer self-pay (Novo NovoCare, Lilly LillyDirect), and cash-pay compounded semaglutide or tirzepatide through US-licensed compounding pharmacies
The company is also investing in comprehensive data, diagnostics and technology infrastructure to enable more personalized services
How Do Hers and Hims Compare to Other GLP-1 Clinics
Food cravings can often derail progress, leading to cycles of stalled weight loss and frustration
For constipation: Add vegetables consistently and increase fluids alongside them
Super gut-friendly formulas